Clinical Trials Browser

Phase 2 × gadobutrol × Clear all

NCT04910425 2025-10-21

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT02796729 2019-01-28

CEST- Glucose Enhanced MRI for Metastatic Brain Tumours

Phase 2 Terminated

Brain Neoplasms, Neoplasm Metastasis